Press Release: Selexys : Selexys Pharmaceuticals Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

(PR-inside.com) Selexys Pharmaceuticals Corporation (Selexys Pharmaceuticals) is a biotechnology company. The company develops drugs for the treatment of inflammatory and thrombotic diseases. Its products include Anti-P-selectin, which blocks selectin function and prevents white blood cells from initiating inflammation and Anti-PSGL-1, a monoclonal antibodies targeted at inflammatory bowel diseases. Selexys Pharmaceuticals provides P-selectin and PSGL-1 for the treatment of acute and chronic inflammatory and thrombotic disorders. The company's research and development activities include preclinical development of antibody-based therapeutics for treating inflammation. Selexys Pharmaceuticals is headquartered in Oklahoma, the US. Selexys Pharmaceuticals Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you ..